<SEC-DOCUMENT>0001437749-24-029996-index.html : 20240925
<SEC-HEADER>0001437749-24-029996.hdr.sgml : 20240925
<ACCEPTANCE-DATETIME>20240925171741
ACCESSION NUMBER:		0001437749-24-029996
CONFORMED SUBMISSION TYPE:	PREM14A
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20241122
FILED AS OF DATE:		20240925
DATE AS OF CHANGE:		20240925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PREM14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		241325455

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREM14A
<SEQUENCE>1
<FILENAME>nby20240924_prem14a.htm
<DESCRIPTION>FORM PREM14A
<TEXT>
Document 1 - file: nby20240924_prem14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>ex_726782.htm
<DESCRIPTION>EXHIBIT FILING FEES
<TEXT>
Document 2 - file: ex_726782.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a01.jpg
<TEXT>
Document 3 - file: a01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a02.jpg
<TEXT>
Document 4 - file: a02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>b01.jpg
<TEXT>
Document 5 - file: b01.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>b02.jpg
<TEXT>
Document 6 - file: b02.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>b03.jpg
<TEXT>
Document 7 - file: b03.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>logo.jpg
<TEXT>
Document 8 - file: logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>